The Canadian Public Drug Claims Database is an essential tool to help:
Develop Budget Impact Analyses (BIA) for public pharmaceutical reimbursement submissions
Prepare for product listing agreement negotiations with the Pan Canadian Pharmaceutical Alliance (PCPA) and the Non-Insured Health Benefits (NIHB) program
Develop Environmental Scans on competitors and various therapeutic areas to understand market threats and potential
The database is a subscription-based online service that offers numerous benefits not available with other data providers, such as:
Cost Effectiveness – Unlike other databases which charge by the report or by the user, the Canadian Drug Claims Database allows company-wide access to the database with one subscription
Accurate Data – Quarterly claims data sourced directly from all provincial drug plans and NIHB so that BIAs contain data that is verifiable by the provincial payers
Easy to Use Interface – The Database features a newly redesigned interface that is user friendly and allows reports to be easily exported to Excel and PDF
PDCI also maintains a Private Payer Claims Database. This database contains detailed patient level claims data that allows for detailed analyses of switching, concomitant use, and longitudinal studies. PDCI utilizes this data to conduct analyses and prepare reports customized to client needs and requests.
The Canadian Public Drug Claims Database is available online and contains detailed drug claims and cost data from the year 2000 onward for provincial and federal drug benefit plans.
Whether you are interested in understanding the public drug plan market potential for a particular therapeutic area or preparing for an important product listing agreement negotiation with a key public payer, the Canadian Public Drug Claims Database is a cost effective, accurate and easy to use tool to help achieve your market access objectives.
For more information regarding our Canadian Public Drug Claims Database or our New Patient Level Data, please contact our Associate Director, Reimbursement Strategy, Paul Henricks at 289-983-6453.